ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Internal Medicine

Top Internal Medicine Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAE YOO MD

Internal Medicine

78,923

$8.54M

1462
1414 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 26%

$108
Average prescription price

Avg: $64

HEW QUON M.D.

Internal Medicine

76,355

$10.5M

931
879 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 26%

$138
Average prescription price

Avg: $64

SANG BAIK

Internal Medicine

74,738

$7.93M

1789
1708 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 26%

$106
Average prescription price

Avg: $64

VLAD NUSINOVICH M.D.

Internal Medicine

52,344

$4.92M

785
712 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 26%

$94
Average prescription price

Avg: $64

MANIKANDA RAJA M.D.

Internal Medicine

51,269

$2.91M

1842
1607 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $64

JUNG BAE M.D.

Internal Medicine

49,949

$3.68M

989
961 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 26%

$74
Average prescription price

Avg: $64

MINAS KOCHUMIAN M.D.

Internal Medicine

47,048

$3.22M

1185
1076 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $64

YOUNG-JIK LEE M.D.

Internal Medicine

45,801

$3.64M

1330
1261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 26%

$79
Average prescription price

Avg: $64

TUAN XUAN NGUYEN MD

Internal Medicine

43,671

$2.98M

857
799 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $64

FARIBORZ SHAMS D.O.

Internal Medicine

43,473

$2.8M

843
580 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $64

EDWARD SVADJIAN MD

Internal Medicine

42,927

$4.37M

571
472 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 26%

$102
Average prescription price

Avg: $64

ELEONORA FEDONENKO M.D.

Internal Medicine

42,719

$4.33M

485
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 26%

$101
Average prescription price

Avg: $64

ILYA RACHMAN M.D.

Internal Medicine

41,987

$4.96M

601
510 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 26%

$118
Average prescription price

Avg: $64

ASHA PRITPAL SIDHU MD

Internal Medicine

41,943

$2.18M

1085
970 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $64

HAROLD HSU M.D.

Internal Medicine

41,491

$3.83M

863
832 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 26%

$92
Average prescription price

Avg: $64

ERNESTO QUINTO DO

Internal Medicine

41,118

$4.36M

19021
16116 are 65+

1%
patients receiving schedule two controlled substances

Avg: 3%

1%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 26%

$106
Average prescription price

Avg: $64

KAIN KUMAR M.D., PHD

Internal Medicine

40,383

$2.84M

1078
532 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

41%
patients receiving schedule three controlled substances

Avg: 13%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $64

YU YAO M.D.

Internal Medicine

40,268

$2.22M

1250
1149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $64

SUNG-NAE BYUN M.D.

Internal Medicine

39,505

$3.14M

906
807 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 26%

$79
Average prescription price

Avg: $64

DAVID LIN DO

Internal Medicine

39,064

$3.22M

994
703 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 26%

$82
Average prescription price

Avg: $64

ASSAD DARAWAL MD

Internal Medicine

37,436

$2.09M

975
804 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $64

AVIVA IOFEL MD

Internal Medicine

37,048

$3.26M

510
450 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 26%

$88
Average prescription price

Avg: $64

KYUNG HAN M.D.

Internal Medicine

35,754

$3.21M

995
916 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 26%

$90
Average prescription price

Avg: $64

CHANDAN CHEEMA MD

Internal Medicine

35,329

$1.85M

1553
1288 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $64

ANANT LODHIA M.D.

Internal Medicine

34,782

$1.95M

1041
832 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank